Synthesis of Cerosome nanoparticles and investigation of the stability and the release of loaded-Gallic acid as bioactive compound

Document Type : Original Research

Authors

1 Department of Nanobiotechnology, Faculty of Biological Science, Tarbiat Modares University, Tehran, Iran

2 Department of Bioactive compounds, Faculty of Interdisciplinary Science and Technologies, Tarbiat Modares University, Tehran, Iran

Abstract
Inflammatory bowel disease is a chronic inflammatory disease of the gastrointestinal tract. Despite numerous endeavors over the past few years, as well as an increase within the number of patients with the disease, there are currently limited medications available to manage intestinal inflammation. Designing a new biological treatment using natural bioactive medications with fewer side effects and more secure transmission than chemical compounds could be advantageous. In this study, a new strategy for the controlled release of Gallic acid as a bioactive polyphenol with anti-inflammatory impacts was proposed. This bioactive compound was loaded on a Cerosome nanocarrier and its stability was investigated. Cerosome-forming lipid (CFL) was synthesized through a two-step chemical reaction and then the Cerosomes were prepared by thin layer hydration by distinctive proportions of DPPC: CFL mole ratio. Cerosome with a mean diameter of 335 nm and zeta potential of -23 mV were homogeneous. The optimal formulation of the Cerosomal gallic acid system shows 34% loading and controlled release of the medication in gastrointestinal fluid environments. Structural stability was systematically evaluated by physicochemical characterization methods, and Cerasomes showed greater stability than liposomes and could be present longer in the bloodstream. These results indicate that Cerasomes can be a better medication delivery system for long-term storage and controllable release of gallic acid and have remarkable applications as carriers of intestinal inflammation drug delivery.

Keywords

Subjects


[1] Z. Vaezi et al.2022.“Hemoglobin bio-adhesive nanoparticles as a colon-specific delivery
system for sustained release of 5-aminosalicylic acid in the effective treatment of
inflammatory bowel disease,” Int. J. Pharm., vol. 616, no. January, p. 121531.
[2] F. Magro, G. Cordeiro, A. M. Dias, and M. M. Estevinho. 2020.“Inflammatory Bowel
Disease – Non-biological treatment,” Pharmacol. Res., vol. 160.
[3] S. Sadeghi Mohammadi, Z. Vaezi, B. Shojaedin-Givi, and H. Naderi-Manesh. 2019.
“Chemiluminescent liposomes as a theranostic carrier for detection of tumor cells under
oxidative stress,” Anal. Chim. Acta, vol. 1059, pp. 113–123.
[4] X. Wang, F. Li, S. Liu, and M. T. Pope. 2005.“New liposome-encapsulatedpolyoxometalates: Synthesis and antitumoral activity,” J. Inorg. Biochem., vol. 99, no. 2,
pp. 452–457.
[5] C. Allen et al .2002.“Controlling the physical behavior and biological performance of
liposome formulations through use of surface grafted poly(ethylene glycol),” Biosci. Rep.,
vol. 22, no. 2, pp. 225–250.
[6] X. Yue and Z. Dai, 2014.“Recent advances in liposomal nanohybrid cerasomes as
promising drug nanocarriers,” Adv. Colloid Interface Sci., vol. 207, no. 1, pp. 32–42.
[7] K. Katagiri, “1999_chemistry letters_1st.pdf,” Chem. Lett.
[8] K. A. B. B. S. H. Lone, Shakeel-U-Rehman. 2016.“Methyl Esters as Effective
Antioxidants,” Drug res, no. 2194–9379, pp. 4–10.
[9] N. Nayeem and A. SMB. 2016.“Gallic Acid: A Promising Lead Molecule for Drug
Development,” J. Appl. Pharm., vol. 08, no. 02, pp. 8–11.
[10] J. S. Wright, E. R. Johnson, and G. A. DiLabio, 2001.“Predicting the activity of phenolic
antioxidants: Theoretical method, analysis of substituent effects, and application to major
families of antioxidants,” J. Am. Chem. Soc., vol. 123, no. 6, pp. 1173–1183.
[11] K. Katagiri, M. Hashizume, K. Ariga, T. Terashima, and J. I. Kikuchi. 2007.“Preparation
and characterization of a novel organic-inorganic nanohybrid ‘cerasome’ formed with a
liposomal membrane and silicate surface,” Chem. - A Eur. J., vol. 13, no. 18, pp. 5272–
5281.
[12] M. Hashizume, S. I. Kawanami, S. Iwamoto, T. Isomoto, and J. I. Kikuchi. 2003.“Stable
vesicular nanoparticle ‘Cerasome’ as an organic-inorganic hybrid formed with
organoalkoxysilane lipids having a hydrogen-bonding unit,” Thin Solid Films, vol. 438–
439, no. 03, pp. 20–26.
[13] Z. Cao, Y. Ma, X. Yue, S. Li, Z. Dai, and J. Kikuchi .2010.“Stabilized liposomal nanohybrid
cerasomes for drug delivery applications,” Chem. Commun., vol. 46, no. 29, pp. 5265–
5267.18
[14] X. Liang et al. 2013.“Design and synthesis of lipidic organoalkoxysilanes for the selfassembly of liposomal nanohybrid cerasomes with controlled drug release properties,”
Chem. - A Eur. J., vol. 19, no. 47, pp. 16113–16121.
[15] Y. Jin, X. Yue, Q. Zhang, X. Wu, Z. Cao, and Z. Dai. 2012.“Cerasomal doxorubicin with
long-term storage stability and controllable sustained release,” Acta Biomater., vol. 8, no.
9, pp. 3372–3380.
[16] Z. Cao, X. Yue, Y. Jin, X. Wu, and Z. Dai. 2012“Modulation of release of paclitaxel from
composite cerasomes,” Colloids Surfaces B Biointerfaces, vol. 98, pp. 97–104.
[17] D. Zhang, H. R. Culver, and C. N. Bowman. 2019.“Hybrid Cerasomes Composed of
Phosphatidylcholines and Silica Networks for the Construction of Vesicular Materials with
Functionalized Shells,” ACS Appl. Nano Mater., vol. 2, no. 12, pp. 7549–7558.
[18] S. Sun et al. 2019.“Bubble-manipulated local drug release from a smart thermosensitive
cerasome for dual-mode imaging guided tumor chemo-photothermal therapy,”
Theranostics, vol. 9, no. 26, pp. 8138–8154.
[19] D. V. Pryazhnikov, O. O. Efanova, and I. V. Kubrakova. 2019.“Cerasomes containing
magnetic nanoparticles: synthesis and gel-filtration chromatographic characterization,”
Mendeleev Commun., vol. 29, no. 2, pp. 226–228.
[20] O. Karatas and F. Gevrek. 2019“Gallic acid liposome and powder gels improved wound
healing in wistar rats,” Ann. Med. Res., vol. 26, no. 12, p. 2720.
[21] A. G. Sagdicoglu Celep, A. Demirkaya, and E. K. Solak. 2020.“Antioxidant and anticancer
activities of gallic acid loaded sodium alginate microspheres on colon cancer,” Curr. Appl.
Phys.